Zastosowanie aglepristonu do przerywania ciazy w 21.-24 dniu po kryciu u kotek

• Autorzy: Jurka P

Warianty tytułu

EN

Use of aglepristone for the termination of pregnancy 21-24 days after mating in female cats

• Języki publikacji: PL

Abstrakty

EN

The aim of this work was to investigate the efficacy of aglepristone in three different doses used to terminate pregnancy 21-24 days after mating in female cats. Cats (n = 43) were divided into three groups with 14 cats in each group and one female cat was described separately. Aglepristone was injected twice, 24 h apart. Female cats in group I received 10 mg/kg subcutaneously (sc), in group II - 12.5 mg/kg sc and in group III - 15 mg/kg. Termination of pregnancy was successful in 9 female cats (64.3%) in group I, seven of which had absorbed embryo and two aborted lifeless fetuses. Four female cats gave birth to healthy kittens between days 62 and 65 of pregnancy. The last female cat gave birth to one live kitten on day 62 of pregnancy post treatment after an ultrasound examination revealed 4 embryos. In group II pregnancy was terminated in 12 female cats (85.7%), 10 of them absorbed embryos and two aborted lifeless fetuses between days 36 and 45 of pregnancy. The remaining two gave birth to live kittens between day 62 and 64 of pregnancy. In group III pregnancy was terminated in 13 female cats (92.8%), 12 of which absorbed embryos and one aborted three lifeless fetuses. The last female cat, post treatment, gave birth to one live kitten on day 61 of pregnancy after ultrasound evaluation showed 5 embryos. This kitten died within 3 days of life. One owner gave her pregnant cat a medroxyprogesterone acetate injection, and although the female cat also receive aglepristone at a dose of 20 mg/kg, she gave birth to two live kittens. The progesterone concentrations were within reference values in the examined groups and increased after the injection of aglepristone. The results indicate that none of the doses of aglepristone used were 100% successful clinically, however the most effective dose was 15 mg/kg. Pruritus at the site of injection immediately after injection was the most common side effect noticed.

Słowa kluczowe

PL

koty; kotki; rozrod zwierzat; przerywanie ciazy; aglepriston; zastosowanie; dawki; skutecznosc; terminy stosowania

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2010
• Tom: 66
• Numer: 04
• Opis fizyczny: s.268-271,tab.,bibliogr.

Twórcy

autor

Jurka P

• Szkola Glowna Gospodarstwa Wiejskiego, ul.Nowoursynowska 159 C, 02-766 Warszawa

Bibliografia

• 1.Bostedt H., Wehrend A., Boryczko Z.: Podstawy i wskazania do stosowania aglepristonu w rozrodzie małych zwierząt. Życie Wet. 2006, 81, 485-487.
• 2.Erunal-Maral N., Aslan S., Findik M., Yuksel N., Handler J., Arbeiter K.: Induction of abortion in queens by administration of cabergoline (Galastop) solely or in combination with the PGF2alpha analogue Alfaprostol (Gabbrostim). Theriogenology 2004, 61, 1471-1475.
• 3.Fieni F., Marnet P. G., Martal J., Siliart B., Touzeau N., Bruyas J. F.: Comparison of two protocols with a P4 antagonist aglepristone (RU 534) to induce parturition in bitches. J. Reprod. Fertil Suppl 2001, 57, 237-242.
• 4.Fieni F., Martal J., Marnet P. G., Siliart B., Guittot F.: Clinical, biological and hormonal study of mid-pregnancy termination in cats with aglepristone Theriogenology 2006, 66, 1721-1728.
• 5.Galac S., Kooistra H. S., Butinar J., Bevers M. M., Dieleman S. J., Voorhout G., Okkens A. C.: Termination of mid-gestation pregnancy in bitches with aglepristone, a progesterone receptor antagonist. Theriogenology 2000, 53, 941-950.
• 6.Georgieva P., Wehrend A.: Mid-gestation pregnancy termination by the progesterone antagonist aglepristone in queens. Theriogenology 2006, 65, 1401-1406.
• 7.Hoffmann B., Schuler G.: Receptor blockers - general aspects with respect to their use in domestic animal reproduction. Anim. Reprod. Sci. 2000, 60/61, 295-312.
• 8.Hubler M., Arnold S.: Prevention of pregnancy in bitches with the progesterone antagonist aglepristone (Alizine). Schweiz. Arch. Tierheilk. 2000, 142, 381-386.
• 9.Jurka P.: Porównanie dwóch metod przerywania niepożądanej ciąży u suk. Medycyna Wet. 2005, 61, 580-582.
• 10.Max A., Jurka P.: Zastosowanie antygestagenu aglepriston (Alizine, Virbac) do wywołania poronienia u suk. Życie Wet. 2006, 81, 196-197.
• 11.Nohr B.: Untersuchungen zur endokrinen Kontrolle der Geburt bei der Hündin unter Anwendung eines Antigestagens. Praca dokt., Justus-Liebig-Universität, Giessen 1999.
• 12.Onclin K., Silva L. D., Verstegen J. P.: Termination of unwanted pregnancy in dogs with the dopamine agonist, cabergoline, in combination with a synthetic analog of PGF2alpha, either cloprostenol or alphaprostol. Theriogenology 1995, 43, 813-822.
• 13.Wanke M., Loza M. E., Monachesi N., Concannon P.: Clinical use of dexamethasone for termination of unwanted pregnancy in dogs. J. Reprod. Fertil. Suppl. 1997, 51, 233-238.